MyFinsight
Home
Blog
About
Contact
onc: the balance sheet
Download
Download image
2030 and thereafter
$28,135K
2029
$8,339K
2027
$8,339K
2026
$8,339K
2026-Selling General And
Administrative Expenses
$67K
2026-Cost Of Sales
$8,272K
2025 (remainder of
year)
$2,090K
Other non-current
assets
$136,197K
Intangible assets, net
$63,581K
Operating lease
right-of-use assets
$140,217K
Property, plant and
equipment, net
$1,628,114K
Prepaid expenses and
other current assets
$232,641K
Inventories, net
$531,687K
Accounts receivable, net
$863,281K
Cash and cash
equivalents
$4,036,868K
Total non-current
assets
$1,968,109K
Total current assets
$5,664,477K
Total assets
$7,632,586K
Total liabilities and
shareholders equity
$7,632,586K
Total shareholders
equity
$4,129,326K
Total liabilities
$3,503,260K
Accumulated deficit
-$8,386,405K
Accumulated other
comprehensive loss
-$101,257K
Additional paid-in capital
$12,616,844K
Total non-current
liabilities
$1,134,835K
Total current
liabilities
$2,368,425K
Ordinary shares, 0.0001
par value per share...
$144K
Other long-term
liabilities
$64,056K
Deferred tax liabilities
$47,066K
Operating lease
liabilities, non-current...
$51,387K
Sale of future
royalty liability,...
$832,755K
Long-term debt
$139,571K
Short-term debt
$813,296K
Sale of future
royalty liability,...
$52,245K
Research and development
cost share...
$90,596K
Operating lease
liabilities, current portion
$15,732K
Tax payable
$11,219K
Accrued expenses and
other payables
$1,001,661K
Accounts payable
$383,676K
Back
Back
Balance Sheet
source: myfinsight.com
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)